Isoniazid is an antibiotic primarily used for the prevention and treatment of tuberculosis (TB). Here are the main usages and details about it:
### 1. **Treatment of Active Tuberculosis**
- **Indication**: Used in combination with other antitubercular agents to treat active TB.
- **Mechanism**: Inhibits the synthesis of mycolic acids, essential components of the bacterial cell wall of Mycobacterium tuberculosis.
### 2. **Latent Tuberculosis Infection (LTBI)**
- **Indication**: Administered to individuals with latent TB to prevent the development of active TB.
- **Duration**: Typically given for 6 to 9 months, depending on the patient's risk factors.
### 3. **Prophylaxis in High-Risk Groups**
- **Indication**: Recommended for individuals at high risk of developing TB, such as those with HIV, recent close contacts of TB patients, and individuals with weakened immune systems.
### 4. **Other Uses**
- Isoniazid may also be used off-label for certain other bacterial infections, although this is less common.
### **Dosage and Administration**
- **Forms**: Available in oral tablets and injectable forms.
- **Dosage**: The typical adult dose for active TB is 5 mg/kg (up to 300 mg) daily, while for LTBI, it's usually 300 mg daily.
### **Side Effects**
Common side effects may include:
- Hepatotoxicity (liver damage)
- Peripheral neuropathy (often mitigated with pyridoxine or vitamin B6)
- Rash
- Gastrointestinal disturbances
### **Monitoring**
Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity, especially in patients with pre-existing liver conditions or those taking other hepatotoxic drugs.
### **Contraindications**
- Significant liver disease
- Previous hypersensitivity reactions to isoniazid
### **Drug Interactions**
Isoniazid can interact with several medications, including:
- Anticonvulsants (e.g., phenytoin)
- Antiretrovirals (e.g., certain protease inhibitors)
- Warfarin (may increase bleeding risk)
### **Summary**
Isoniazid is a crucial medication in the fight against tuberculosis, particularly in preventing the progression from latent to active disease. Its use should be carefully monitored to manage potential side effects and interactions.